Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about Press Release

21 May 2015 Evaluate

Glenmark Pharmaceuticals has informed about Press Release dated May 21, 2015, titled ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Rufinamide Tablets USP’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1758.10
Dr. Reddys Labs. 1342.50
Cipla 1363.25
Lupin 1985.75
Zydus Lifesciences 1178.95
View more..